This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.
The use of hearing aids and cochlear implants reduced long-term cognitive decline by 19%. ... The study involved a meta-analysis of 31 studies comprising 137, 484 participants to determine the long-term associations of hearing aids and cochlear implants
This rise was driven by a nearly 40% increase in sales for its etonogestrel implant, Nexplanon.
Durysta (bimatoprost implant) is the first biodegradable, sustained-release implant for IOP in patients with open-angle glaucoma or ocular hypertension. ... As the first FDA-approved intracameral, biodegradable sustained-release implant providing
The German drugmaker is already a major player in the women’s health market, selling a range of contraceptive products including oral and injectable hormonal products and implants, and is one ... Bayer hasn’t had the happiest recent history in the
from defective breast implants manufactured by Poly Implant Prothese (PIP).
Meanwhile, Merck &Co/MSD presented preliminary results with a new HIV drug – islatravir (MK-8591) – that it believes could offer a year of anti-HIV activity from a single implant, rather
More from news
Approximately 2 fully matching, plus 94 partially matching documents found.
such as the group litigation order (GLO) for silicone breast implants.
Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria
PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and
Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable
The acquisition provides Innocoll with the financial resources to continue the development of its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant
This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
The implant will then fully degrade within a year, so no invasive removal surgery is needed. ... Published March 11, 2015. Accessed November 3, 2021. Knowles K. This start-up is 3D printing breast implants for cancer survivors.
The mesh implant scandal is just one example.”. Thrive’s Digital opportunities for women’s wellbeing white paper explores the barriers to truly closing the health gap and potential solutions in
There was a 3% decrease in uptake of long-acting reversible contraceptives (LARCs) – e.g., contraceptive implants, intrauterine devices (IUDs) and injectables.
latest technologies around artificial intelligence, deep learning, data analytics, genomics, home‑based healthcare, robotics, and 3D printing of tissues and implants.”.
Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk's Neuralink and the Future of the Computer Brain Interface. Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto. Ontario. M5J
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
No results were found
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...